KIDNEY TRANSPLANTATION
Clinical trials for KIDNEY TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANTATION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney transplant drug switch aims to reduce Long-Term complications
Disease control TerminatedThis study looked at whether switching kidney transplant patients from tacrolimus to sirolimus (both with mycophenolate mofetil) could lower the risk of kidney damage, new diabetes, and cancer. It involved 65 stable transplant recipients between 1 and 3 years after their transpla…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Kidney transplant breakthrough? drug combo aims to reduce lifelong pills
Disease control TerminatedThis study tested a drug called siplizumab combined with donor bone marrow cells to help kidney transplant patients potentially stop taking anti-rejection drugs long-term. Only 4 people took part before the study was ended early. The goal was to find the best dose to safely allow…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New drug aims to help kidney transplants last longer
Disease control TerminatedThis study tested a new medicine called TCD601 (siplizumab) in people who just received a new kidney. The goal was to see if it is safe and helps prevent the body from rejecting the kidney, compared to a standard treatment. The study was stopped early, but the results will help d…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
Kidney transplant patients may get simpler drug routine
Disease control TerminatedThis study tested whether a once-daily anti-rejection drug (EnvarsusXR) combined with azathioprine works as well as the standard twice-daily drug combo after a kidney transplant. The goal was to prevent organ rejection while keeping the kidney working and the patient alive. The s…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE4 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 01, 2026 17:53 UTC
-
New ultrasound technique aims to catch kidney transplant trouble sooner
Diagnosis TerminatedThis study tested a special ultrasound that uses a contrast dye to get clearer images of a new kidney after transplant. The goal was to see if this method could help doctors find early signs of problems like rejection or slow function. The study was small (20 people) and was stop…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1 • Sponsor: University of Utah • Aim: Diagnosis
Last updated Jun 08, 2026 13:10 UTC